RTTNews) - Gilead Sciences Inc. (GILD) announced that phase 1 study data showed two different formulations of once-yearly lenacapavir, administered via intramuscular injection, achieved and maintained plasma concentrations exceeding those associated with HIV prevention efficacy...
.png)
245 Victoria Avenue, MARGATE QLD 4019, 245
0460555001
darrin@pictureperfectcatering.com.au
Copyright © 2023 pictureperfectnews. All Rights Reserved
